PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-06 (5)

Date Title Company
06-Mar-2026 Kallyope to Present Phase 2b Study Results for Elismetrep for the Acute Treatment of Migraine at the 2026 American Academy of Neurology Annual Meeting Businesswire